Khattar Jack A.
President, CEO at SUPERNUS PHARMACEUTICALS, INC.
- Sold, on record
- $39.3M
- Dollars the filings state
- Form 4 sales
- 31
- Latest Mar 13, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SUPERNUS PHARMACEUTICALS, INC.President, CEO
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.RoutineSep 22 2025
Sold 16,587 shares at $47.02 ($780k)
Khattar Jack A., President, CEO
10b5-1 planSold 1.5% of holdings ($53.6M position)1.1M shares left0.4x usual sizeFiling
- 2 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.RoutineSep 23 +1 day
Sold 29,513 shares at $47.23 ($1.4M)
Khattar Jack A., President, CEO
10b5-1 planSold 2.5% of holdings ($55.3M position)1.1M shares left0.8x usual sizeFiling
- 3 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.RoutineSep 29 +6 days
Sold 10,235 shares at $48.02 ($491k)
Khattar Jack A., President, CEO
10b5-1 planSold 0.9% of holdings ($55.4M position)1.1M shares left0.3x usual sizeFiling
- 4 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.RoutineSep 30 +1 day
Sold 8,588 shares at $48.25 ($414k)
Khattar Jack A., President, CEO
10b5-1 planSold 0.7% of holdings ($55.8M position)1.1M shares left0.3x usual sizeFiling
- 5 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.RoutineOct 1 +1 day
Sold 40,173 shares at $48.07 ($1.9M)
Khattar Jack A., President, CEO
10b5-1 planSold 3.3% of holdings ($57.7M position)1.2M shares left1.7x usual sizeFiling
- 6 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.RoutineOct 2 +1 day
Sold 1,904 shares at $48.06 ($92k)
Khattar Jack A., President, CEO
10b5-1 planSold 0.2% of holdings ($55.9M position)1.2M shares left0.1x usual sizeFiling
- 7 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.RoutineOct 9 +7 days
Sold 59,900 shares at $50.57 ($3M)
Khattar Jack A., President, CEO
10b5-1 planSold 4.7% of holdings ($64M position)1.2M shares left2.6x usual sizeFiling
- 8 Form 4 sale SUPERNUS PHARMACEUTICALS, INC.RoutineMar 13 +155 days
Sold 35,000 shares at $50.37 ($1.8M)
Khattar Jack A., President, CEO
10b5-1 planSold 3.5% of holdings ($50M position)958,100 shares left1.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (31)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 35,000 | $1.8M | 3.5% | Routine | SEC |
| Oct 9, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 59,900 | $3M | 4.7% | Routine | SEC |
| Oct 2, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 1,904 | $92k | 0.2% | Routine | SEC |
| Oct 1, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 40,173 | $1.9M | 3.3% | Routine | SEC |
| Sep 30, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 8,588 | $414k | 0.7% | Routine | SEC |
| Sep 29, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 10,235 | $491k | 0.9% | Routine | SEC |
| Sep 23, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 29,513 | $1.4M | 2.5% | Routine | SEC |
| Sep 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 16,587 | $780k | 1.5% | Routine | SEC |
| Sep 8, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 6,322 | $293k | 0.6% | Routine | SEC |
| Sep 5, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 55,578 | $2.6M | 4.8% | Routine | SEC |
| Aug 28, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 34,800 | $1.6M | 3.1% | Routine | SEC |
| Aug 25, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 1,000 | $45k | 0.1% | Routine | SEC |
| Aug 22, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 1,500 | $68k | 0.1% | Routine | SEC |
| Aug 6, 2025 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 140,000 | $5.9M | 11.6% | Routine | SEC |
| Nov 8, 2024 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 125,000 | $4.5M | 11.9% | Unusual | SEC |
| Nov 7, 2024 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 125,000 | $4.6M | 11.9% | Unusual | SEC |
| Feb 2, 2023 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 13,532 | $569k | 1.7% | Plan not stated | SEC |
| Feb 1, 2023 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 300 | $13k | 0.0% | Plan not stated | SEC |
| Jan 31, 2023 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 976 | $41k | 0.1% | Plan not stated | SEC |
| Jan 18, 2023 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 4,936 | $199k | 0.6% | Plan not stated | SEC |
| Jan 17, 2023 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 25,446 | $1M | 3.1% | Plan not stated | SEC |
| Dec 21, 2022 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 15,360 | $585k | 1.9% | Plan not stated | SEC |
| Nov 25, 2022 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 13,394 | $471k | 1.7% | Plan not stated | SEC |
| Nov 22, 2022 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 600 | $21k | 0.1% | Plan not stated | SEC |
| Nov 21, 2022 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 531 | $19k | 0.1% | Plan not stated | SEC |
| Nov 15, 2022 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 1,115 | $39k | 0.1% | Plan not stated | SEC |
| Aug 16, 2022 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 14,690 | $500k | 1.9% | Plan not stated | SEC |
| Aug 15, 2022 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 17,302 | $589k | 2.2% | Plan not stated | SEC |
| Aug 10, 2022 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 28,437 | $888k | 3.7% | Plan not stated | SEC |
| Aug 9, 2022 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 39,431 | $1.2M | 5.2% | Plan not stated | SEC |
| Aug 8, 2022 | SUPERNUS PHARMACEUTICALS, INC. | President, CEO | Form 4 sale | 117,907 | $3.7M | 14.4% | Plan not stated | SEC |